Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RANI

Rani Therapeutics (RANI)

Rani Therapeutics Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RANI
DateTimeSourceHeadlineSymbolCompany
12/17/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
12/17/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
12/16/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
12/10/202412:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RANIRani Therapeutics Holdings Inc
11/14/20247:20AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RANIRani Therapeutics Holdings Inc
11/14/20247:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
11/14/20247:00AMGlobeNewswire Inc.Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
11/07/20243:05PMGlobeNewswire Inc.Rani Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
10/17/20247:00AMGlobeNewswire Inc.Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin TriagonistNASDAQ:RANIRani Therapeutics Holdings Inc
10/16/20245:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
10/16/20245:04AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RANIRani Therapeutics Holdings Inc
10/15/20247:30AMGlobeNewswire Inc.Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing WarrantsNASDAQ:RANIRani Therapeutics Holdings Inc
10/08/20243:05PMGlobeNewswire Inc.Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:RANIRani Therapeutics Holdings Inc
09/11/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
09/03/20243:05PMGlobeNewswire Inc.Rani Therapeutics to Participate in September Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
08/06/20243:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RANIRani Therapeutics Holdings Inc
08/06/20243:05PMGlobeNewswire Inc.Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
08/06/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
07/29/20243:05PMGlobeNewswire Inc.Rani Therapeutics to Participate in August Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
07/23/20245:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
07/23/20245:05AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RANIRani Therapeutics Holdings Inc
07/22/20247:30AMGlobeNewswire Inc.Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct OfferingNASDAQ:RANIRani Therapeutics Holdings Inc
07/12/20244:19PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
06/24/20246:00AMGlobeNewswire Inc.Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity TreatmentNASDAQ:RANIRani Therapeutics Holdings Inc
05/30/20243:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
05/14/20247:00AMGlobeNewswire Inc.Rani Therapeutics to Participate in May Investor ConferencesNASDAQ:RANIRani Therapeutics Holdings Inc
05/09/20247:00AMGlobeNewswire Inc.Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024NASDAQ:RANIRani Therapeutics Holdings Inc
05/06/20243:09PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RANIRani Therapeutics Holdings Inc
05/06/20243:05PMGlobeNewswire Inc.Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate UpdateNASDAQ:RANIRani Therapeutics Holdings Inc
05/06/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RANIRani Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:RANI